Task: Answer the multiple-choice question.
Query: Which drug exhibits a 14.718\% hERG inhibition at 1uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
(a) Cc1ccc(-c2csc3nnc(SCC(=O)Nc4nsc(-c5ccccc5)n4)n23)cc1
(b) O=C(NCCCN1CCCC1=O)c1cccc(Oc2ccccc2)c1
(c) Brc1ccc(C=Nc2ccc(Nc3ccccc3)cc2)s1
Answer: c. Brc1ccc(C=Nc2ccc(Nc3ccccc3)cc2)s1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_1uM#}{herg_central_at_1uM__units} {herg_central_at_1uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_1uM%}
Answer: {%multiple_choice_result}. {SMILES#}
Brc1ccc(C=Nc2ccc(Nc3ccccc3)cc2)s1
Brc1ccc(C=Nc2ccc(Nc3ccccc3)cc2)s1
4-[(5-bromothiophen-2-yl)methylideneamino]-N-phenylaniline